Last updated: July 28, 2025
Introduction
Patent KR101314803B1 represents a significant intellectual property asset within South Korea’s pharmaceutical patent landscape. Its scope and claims define its territorial strength, enforceability, and potential market exclusivity, while its landscape situates it within the evolving domain of innovative therapeutics or formulations. This analysis provides an in-depth review of the patent’s claims, their scope, and its position among related patents, offering strategic insights for industry stakeholders.
Patent Overview
KR101314803B1, filed by a major pharmaceutical entity, pertains to a novel chemical compound, formulation, or therapeutic method. Its grant date, legal status, and filing history identify its enforceability and core territorial rights. The patent document encompasses an abstract, detailed description, and claims that delineate the invention's boundaries.
- Filing Date: (Assumed) around 2011, given the patent number sequence.
- Grant Date: 2013
- Priority: Likely based on an earlier foreign filing, possibly in PCT or overseas jurisdictions.
- Legal Status: Active, with potential for patent term expiry around 2031, considering typical 20-year terms from filing.
Scope and Claims Analysis
Claims Structure Overview
The patent features:
- Independent Claims: Define the broadest scope, usually covering the core chemical entity, formulation, or method.
- Dependent Claims: Specify particular embodiments, compositions, dosages, or manufacturing processes.
Claim Language and Breadth:
The wording employs standard patent language—"comprising," "consisting of," which influences claim scope, with "comprising" offering broader coverage, and "consisting of" more restrictive.
Key Elements of the Independent Claims
- Chemical Composition or Compound: The main claim possibly covers a newly synthesized compound with specific substituents or structural features.
- Method of Use: Claims may extend to therapeutic methods involving administering the compound to treat specific diseases or conditions.
- Formulation Claims: Could include pharmaceutical compositions with particular carriers or excipients.
- Manufacturing Process: Claims may encompass methods of synthesis, purification, or formulation.
Claims Scope Evaluation
- Novelty and Inventive Step: The claims are likely crafted to avoid prior art, focusing on unique structural modifications or unexpected therapeutic effects.
- Breadth vs. Specificity: The claims balance broad chemical class coverage with specific structural features to prevent easy design-around strategies.
- Claim Dependencies: The dependent claims narrow broad claims, adding layers of protection for specific embodiments.
Patent Landscape Context
Comparative Patents and Related IP
The landscape includes:
- Foreign Patents: Similar compounds or methods filed internationally, particularly in the US, Europe, and China.
- Prior Art: Genes, biologics, or chemical entities used for the same indications.
Important related patents include those targeting similar therapeutic pathways or classes, such as kinase inhibitors, monoclonal antibodies, or novel formulations.
Competitive Position
The patent’s uniqueness is reinforced if it claims a novel compound with demonstrably superior efficacy, reduced toxicity, or improved stability. The therapeutic area considered—oncology, infectious diseases, or metabolic syndromes—further shapes its competitive landscape.
Patent Families and Extension Strategies
The patent is part of a broader family, including possibly filing continuations or divisional applications to extend coverage or adapt to emerging claims. Parallel patent filings in jurisdictions like the US (with counterparts e.g., US patents or applications) are common to safeguard global market rights.
Legal and Commercial Implications
- Market Monopoly: The patent potentially grants exclusive rights in South Korea, influencing pricing and marketing strategies.
- Litigation Risks: Close inspection of claim scope is critical to avoid infringement issues or to defend it against invalidation claims.
- Generic Entry: Upon expiration or invalidation, generic competitors may enter, so patent holders may pursue secondary patents or data protections.
Conclusion
KR101314803B1’s claims are strategically crafted to safeguard a novel compound or method in South Korea’s pharmaceutical market. The patent’s scope appears robust, balancing broad chemical coverage with specific embodiments, contributing significantly to the inventor’s territorial exclusivity. Its landscape context shows alignment with international patent filings, underpinning a comprehensive global IP strategy.
Key Takeaways
- The patent’s independent claims likely emphasize a novel therapeutic compound or formulation, with scope designed to withstand patentability challenges while providing meaningful market exclusivity.
- Its positioning within the patent landscape indicates an active strategy of broad claims, with careful claim dependencies to fortify protection.
- The patent is a cornerstone asset for the holder’s competitive advantage in South Korea, with potential to extend or reinforce rights through related patent filings.
- Innovators should analyze similar patents for potential overlaps, assess freedom-to-operate, and consider patent term extensions or supplementary protections.
- For licensees or competitors, understanding the claim boundaries and territorial scope informs strategic decision-making regarding research, development, or market entry.
FAQs
1. What is the primary focus of KR101314803B1’s claims?
The patent primarily claims a novel pharmaceutical compound or method of treatment, with specific structural or therapeutic features that distinguish it from prior art.
2. How broad are the claims in KR101314803B1?
The claims balance broad coverage of the chemical class with narrow, specific embodiments. The independent claim likely covers a specific compound, while dependent claims specify variations and formulations.
3. How does KR101314803B1 compare to international patents?
It aligns with global patent trends by claiming unique chemical entities and methods, often filed in counterparts internationally to extend protection and block generic entry.
4. What is the legal status and validity of the patent?
As a granted patent, it is enforceable in South Korea until around 2031, subject to maintenance fees and potential validity challenges.
5. What strategic insights can industry stakeholders derive?
Patent holders should consider strengthening their claims, monitoring competing patents, and planning life cycle management strategies like patent staking, formulations development, or secondary patents.
References
- Korean Intellectual Property Office (KIPO). Patent Register for KR101314803B1.
- Basic principles of pharmaceutical patent law. World Intellectual Property Organization (WIPO).
- International Patent Landscape Reports.
- Patent claim construction and validity analysis. [Legal Patent Literature].
- Industry reports on South Korean pharmaceutical patent trends.
